Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manjari Pandey

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancers|February 6, 2021
<i>TP53</i> Mutations as a Driver of Metastasis Signaling in Advanced Cancer PatientsRitu Pandey, Nathan Johnson, Laurence Cooke, et al.
Journal of Ovarian Research|August 28, 2016
Genomic alterations in neuroendocrine cancers of the ovaryGeorge Yaghmour, Philippe Prouet, Eric Wiedower, et al.
CNS Oncology|September 6, 2021
Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastomaNgan Nguyen, Jordan Redfield, Matthew Ballo, et al.
Neuro-Oncology Advances|October 17, 2022
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experienceMatthew T Ballo, Kaitlin W Qualls, L Madison Michael, et al.
Breast Cancer Research and Treatment|June 23, 2016
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.
Anticancer Research|July 29, 2016
Role of Genomic Instability in Immunotherapy with Checkpoint InhibitorsGeorge Yaghmour, Manjari Pandey, Catherine Ireland, et al.
JCO Precision Oncology|February 1, 2022
Tumor Mutational Burden Is Site Specific in Non-Small-Cell Lung Cancer and Is Highest in Lung Adenocarcinoma Brain MetastasesMatthew K Stein, Manjari Pandey, Joanne Xiu, et al.
Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.
Journal for Immunotherapy of Cancer|August 25, 2019
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200Daruka Mahadevan, Mark C Lanasa, Charles Farber, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancers|February 6, 2021
<i>TP53</i> Mutations as a Driver of Metastasis Signaling in Advanced Cancer PatientsRitu Pandey, Nathan Johnson, Laurence Cooke, et al.
Journal of Ovarian Research|August 28, 2016
Genomic alterations in neuroendocrine cancers of the ovaryGeorge Yaghmour, Philippe Prouet, Eric Wiedower, et al.
CNS Oncology|September 6, 2021
Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastomaNgan Nguyen, Jordan Redfield, Matthew Ballo, et al.
Neuro-Oncology Advances|October 17, 2022
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experienceMatthew T Ballo, Kaitlin W Qualls, L Madison Michael, et al.
Breast Cancer Research and Treatment|June 23, 2016
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.
Anticancer Research|July 29, 2016
Role of Genomic Instability in Immunotherapy with Checkpoint InhibitorsGeorge Yaghmour, Manjari Pandey, Catherine Ireland, et al.
JCO Precision Oncology|February 1, 2022
Tumor Mutational Burden Is Site Specific in Non-Small-Cell Lung Cancer and Is Highest in Lung Adenocarcinoma Brain MetastasesMatthew K Stein, Manjari Pandey, Joanne Xiu, et al.
Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.
Journal for Immunotherapy of Cancer|August 25, 2019
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200Daruka Mahadevan, Mark C Lanasa, Charles Farber, et al.
Pageof 3